Drug intelligence / Profile preview

Jin Yin Hua Keli (Senkeyuan)

Development stage: Unknown
Lead developer: Senkeyuan
Administration: Oral

Overview

Jin Yin Hua Keli (Honeysuckle Granules) is a traditional Chinese herbal medicine developed and manufactured by Sichuan Senke Pharmaceutical Co., Ltd. under the brand name Senkeyuan. The formulation is derived from honeysuckle (*Lonicera japonica*) and is presented as light yellow oral granules. It is indicated for the treatment of fever accompanied by thirst, sore throat, and pediatric fetal toxicity. Within the framework of traditional Chinese medicine, the drug functions by clearing heat and detoxifying. It is classified as a non-prescription (OTC) drug in China and is administered orally after being dissolved in water.

Brand names: Senkeyuan森科源
Other names: Jin Yin Hua KeliHoneysuckle Granules金银花颗粒

Beyond the preview

Go deeper on Jin Yin Hua Keli (Senkeyuan).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jin Yin Hua Keli (Senkeyuan).

Explore the full profile